Deferred Income Tax Assets, Net in USD of RECURSION PHARMACEUTICALS, INC. from Q4 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary
RECURSION PHARMACEUTICALS, INC. quarterly Deferred Income Tax Assets, Net history and change rate from Q4 2023 to Q3 2025.
  • RECURSION PHARMACEUTICALS, INC. Deferred Income Tax Assets, Net for the quarter ending 30 Sep 2025 was $957K.
Deferred Income Tax Assets, Net, Quarterly (USD)

RECURSION PHARMACEUTICALS, INC. Quarterly Deferred Income Tax Assets, Net (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $957K 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $957K 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 $2M 31 Mar 2025 10-Q 05 May 2025
Q4 2024 $1.93M +$1.93M 31 Dec 2024 10-Q 05 Nov 2025
Q4 2023 $0 31 Dec 2023 10-K 28 Feb 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.